Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karina S, Simon"'
Autor:
Priscilla Galante, Gabriel A. A. Campos, Jacqueline C. G. Moser, Danubia B. Martins, Marcia P. dos Santos Cabrera, Marisa Rangel, Luiza C. Coelho, Karina S. Simon, Veronica M. Amado, Jessica de A. I. Muller, Johannes Koehbach, Rink-Jan Lohman, Peter J. Cabot, Irina Vetter, David J. Craik, Monica C. Toffoli-Kadri, Victoria Monge-Fuentes, Jair T. Goulart, Elisabeth F. Schwartz, Luciano P. Silva, Anamelia L. Bocca, Márcia R. Mortari
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Animal venoms are rich sources of neuroactive compounds, including anti-inflammatory, antiepileptic, and antinociceptive molecules. Our study identified a protonectin peptide from the wasp Parachartergus fraternus' venom using mass spectrome
Externí odkaz:
https://doaj.org/article/b67d9db1535243309705120d264359b7
Autor:
Fernanda Guilhelmelli, Nathália Vilela, Karina S. Simon, Marco Antonio de Oliveira, Alice CM Álvares, Maria Célia L. Rigonatto, Pedro Henrique S. Costa, Aldo H. Tavares, Sônia M. Freita, Andre Moraes Nicola, Octavio Luiz Franco, Lorena S. Derengowski, Elisabeth F. Schwartz, Márcia Renata Mortari, Anamelia Lorenzetti Bocca, Patrícia Albuquerque, Ildinete Silva-Pereira
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
The incidence of fungal infections has been increasing in the last decades, while the number of available antifungal classes remains the same. The natural and acquired resistance of some fungal species to available therapies, associated with the high
Externí odkaz:
https://doaj.org/article/2c80ecacabc142eb97d37bef9ae34d5e
Autor:
Haroldo C, de Oliveira, Luna S, Joffe, Karina S, Simon, Rafael F, Castelli, Flavia C G, Reis, Arielle M, Bryan, Beatriz S, Borges, Lia C Soares, Medeiros, Anamelia L, Bocca, Maurizio, Del Poeta, Marcio L, Rodrigues
Publikováno v:
Antimicrob Agents Chemother
The human diseases caused by the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii are associated with high indices of mortality and toxic and/or cost-prohibitive therapeutic protocols. The need for affordable antifungals to combat cry